AbbVie News and Activities

Presence

AbbVie develops and sells medicines for immune disorders, cancer, neuroscience, and other serious diseases. Its products and services serve patients, healthcare professionals, hospitals, and health systems worldwide.

AbbVie products and services overview:

Immunology medicines
Oncology therapies
Neuroscience medicines
Aesthetic products
Eye care
Medical devices

Revenue: ~$56 billion

Employees: 55,000

Headquarters: North Chicago, United States (USA)

AbbVie is one of the...

AbbVie is a company listed under the stock ticker ABBV (US).

AbbVie has a direct presence in 21 countries.

AbbVie has 27 subsidiaries including AbbVie APAC, AbbVie Australia and AbbVie Belgium.

They are in:

Acquisition, funding and merger involving AbbVie.

AbbVie has announced the acquisition of Apogee Therapeutics (posted on June 23 2026).
AbbVie has announced the acquisition of Kestrel Therapeutics (posted on April 29 2026).
Capstan Therapeutics and AbbVie have merged (posted on August 19 2025)..
AbbVie has announced the acquisition of Capstan Therapeutics (posted on July 1 2025).
AbbVie has acquired Cerevel Therapeutics (posted on August 5 2024).
See more news about AbbVie Hide news involving AbbVie

Executives

View the org chart displaying its 230 main executives

Most searched biographies at AbbVie

Popular executive movements at AbbVie

Ian McCaffery, Vice President and Head of Precision Medicine and Companion Diagnostics, has left the company (posted on July 6 2026).
Dina Gofis has joined the company as Director Business Human Resources, Us Specialty Commercial (posted on November 11 2025).
Greg Miley, Senior Vice President, Government Affairs, has left the company (posted on October 23 2025).

Create your alert
to follow the executive moves at AbbVie.